Transdermal oestrogen therapy protects postmenopausal liver transplant women from osteoporosis. A 2-year follow-up study
- 1 February 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 34 (2) , 299-305
- https://doi.org/10.1016/s0168-8278(00)00067-2
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Safety and efficacy of transdermal estradiol replacement therapy in postmenopausal liver transplanted womenActa Obstetricia et Gynecologica Scandinavica, 1998
- Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantationEuropean Journal of Clinical Investigation, 1996
- Organ transplantation and osteoporosisCurrent Opinion in Rheumatology, 1995
- A simple method for predicting bone fractures in PBC patients after liver transplantationTransplant International, 1994
- The Prevention and Treatment of OsteoporosisNew England Journal of Medicine, 1992
- Appendicular bone mineral and a woman's lifetime risk of hip fractureJournal of Bone and Mineral Research, 1992
- Consensus development conference: prophylaxis and treatment of osteoporosisThe American Journal of Medicine, 1991
- Cyclosporin-Ain VivoProduces Severe Osteopenia in the Rat: Effect of Dose and Duration of Administration*Endocrinology, 1988
- Prospective trial of oestrogen and calcium in postmenopausal women.BMJ, 1977
- LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGENThe Lancet, 1976